Cancer and COVID-19: analysis of patient outcomes.
Mohamed A AboueishaMohammad Hosny HusseinAbdallah S AttiaAubrey SwinfordPeter MillerMahmoud OmarEman Ali ToraihNakhle SabaHana SafahJuan DuchesneEmad KandilPublished in: Future oncology (London, England) (2021)
Background: We sought to investigate the outcomes associated with COVID-19 disease in cancer patients. Methods: We conducted a retrospective cohort study of laboratory-confirmed COVID-19 patients. Results: Of the 206 patients included, 57 had at least one preexisting malignancy. Cancer patients were older than noncancer patients. Of the 185 discharged cases, cancer patients had a significantly higher frequency of unplanned reintubation (7.1% vs 0.9%, p < 0.049), and required longer hospital stay (8.58 ± 6.50 days versus 12.83 ± 11.44 days, p < 0.002). Regression analysis revealed that obesity and active smoking were associated with an increased risk of mortality. Conclusion: Outcomes in COVID-19 appear to be driven by obesity as well as active smoking, with no difference in mortality between cancer and noncancer patients.
Keyphrases
- end stage renal disease
- sars cov
- coronavirus disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- type diabetes
- peritoneal dialysis
- healthcare
- metabolic syndrome
- prognostic factors
- insulin resistance
- weight loss
- emergency department
- body mass index
- cardiovascular disease
- physical activity
- cardiovascular events
- papillary thyroid
- coronary artery disease
- young adults
- squamous cell carcinoma
- patient reported
- respiratory syndrome coronavirus
- electronic health record